{"id":"https://openalex.org/W2913583138","doi":"https://doi.org/10.1111/dth.12843","title":"The analysis of the therapeutic potential of ustekinumab in psoriasis vulgaris treatment","display_name":"The analysis of the therapeutic potential of ustekinumab in psoriasis vulgaris treatment","publication_year":2019,"publication_date":"2019-01-29","ids":{"openalex":"https://openalex.org/W2913583138","doi":"https://doi.org/10.1111/dth.12843","mag":"2913583138","pmid":"https://pubmed.ncbi.nlm.nih.gov/30693647"},"language":"en","primary_location":{"id":"doi:10.1111/dth.12843","doi":"https://doi.org/10.1111/dth.12843","is_oa":false,"landing_page_url":"https://doi.org/10.1111/dth.12843","pdf_url":null,"source":{"id":"https://openalex.org/S67424211","display_name":"Dermatologic Therapy","issn_l":"1396-0296","issn":["1396-0296","1529-8019"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-1","norway-1","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Dermatologic Therapy","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5086505040","display_name":"Dominika Ligia Wcis\u0142o-Dziadecka","orcid":"https://orcid.org/0000-0003-0501-7592","observed_orcids":["https://orcid.org/0000-0003-0501-7592"]},"institutions":[{"id":"https://openalex.org/I166182418","display_name":"Medical University of Silesia","ror":"https://ror.org/005k7hp45","country_code":"PL","type":"education","lineage":["https://openalex.org/I166182418"]}],"countries":["PL"],"is_corresponding":true,"raw_author_name":"Dominika Wcis\u0142o\u2010Dziadecka","raw_affiliation_strings":["Chair and Department of Cosmetology, School of Pharmacy with Division of Laboratory Medicine in Sosnowiec, Medical University of Silesia, Sosnowiec, Poland"],"raw_orcid":"https://orcid.org/0000-0003-0501-7592","affiliations":[{"raw_affiliation_string":"Chair and Department of Cosmetology, School of Pharmacy with Division of Laboratory Medicine in Sosnowiec, Medical University of Silesia, Sosnowiec, Poland","institution_ids":["https://openalex.org/I166182418"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033113181","display_name":"Beniamin Oskar Grabarek","orcid":"https://orcid.org/0000-0003-1633-7145","observed_orcids":["https://orcid.org/0000-0003-1633-7145"]},"institutions":[{"id":"https://openalex.org/I166182418","display_name":"Medical University of Silesia","ror":"https://ror.org/005k7hp45","country_code":"PL","type":"education","lineage":["https://openalex.org/I166182418"]}],"countries":["PL"],"is_corresponding":false,"raw_author_name":"Beniamin Grabarek","raw_affiliation_strings":["Department of Molecular Biology, School of Pharmacy with the Division of Laboratory Medicine in Sosnowiec, Medical University of Silesia, Sosnowiec, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Molecular Biology, School of Pharmacy with the Division of Laboratory Medicine in Sosnowiec, Medical University of Silesia, Sosnowiec, Poland","institution_ids":["https://openalex.org/I166182418"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007619655","display_name":"Celina Kruszniewska\u2010Rajs","orcid":"https://orcid.org/0000-0002-2504-6289","observed_orcids":["https://orcid.org/0000-0002-2504-6289"]},"institutions":[{"id":"https://openalex.org/I166182418","display_name":"Medical University of Silesia","ror":"https://ror.org/005k7hp45","country_code":"PL","type":"education","lineage":["https://openalex.org/I166182418"]}],"countries":["PL"],"is_corresponding":false,"raw_author_name":"Celina Kruszniewska\u2010Rajs","raw_affiliation_strings":["Department of Molecular Biology, School of Pharmacy with the Division of Laboratory Medicine in Sosnowiec, Medical University of Silesia, Sosnowiec, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Molecular Biology, School of Pharmacy with the Division of Laboratory Medicine in Sosnowiec, Medical University of Silesia, Sosnowiec, Poland","institution_ids":["https://openalex.org/I166182418"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5039824494","display_name":"Barbara Strza\u0142ka\u2010Mrozik","orcid":"https://orcid.org/0000-0001-9854-2569","observed_orcids":["https://orcid.org/0000-0001-9854-2569"]},"institutions":[{"id":"https://openalex.org/I166182418","display_name":"Medical University of Silesia","ror":"https://ror.org/005k7hp45","country_code":"PL","type":"education","lineage":["https://openalex.org/I166182418"]}],"countries":["PL"],"is_corresponding":false,"raw_author_name":"Barbara Strza\u0142ka\u2010Mrozik","raw_affiliation_strings":["Department of Molecular Biology, School of Pharmacy with the Division of Laboratory Medicine in Sosnowiec, Medical University of Silesia, Sosnowiec, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Molecular Biology, School of Pharmacy with the Division of Laboratory Medicine in Sosnowiec, Medical University of Silesia, Sosnowiec, Poland","institution_ids":["https://openalex.org/I166182418"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5086505040"],"corresponding_institution_ids":["https://openalex.org/I166182418"],"apc_list":{"value":3100,"currency":"USD","value_usd":3100},"apc_paid":null,"fwci":0.5874,"has_fulltext":false,"cited_by_count":10,"citation_normalized_percentile":{"value":0.60206806,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":97},"biblio":{"volume":"32","issue":"3","first_page":"e12843","last_page":"e12843"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10469","display_name":"Psoriasis: Treatment and Pathogenesis","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10469","display_name":"Psoriasis: Treatment and Pathogenesis","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10837","display_name":"Dermatology and Skin Diseases","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11092","display_name":"Spondyloarthritis Studies and Treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ustekinumab","display_name":"ustekinumab","score":1.0},{"id":"https://openalex.org/keywords/plaque-psoriasis","display_name":"plaque psoriasis","score":0.9990000128746033},{"id":"https://openalex.org/keywords/il-12-23-inhibition","display_name":"IL-12/IL-23 inhibition","score":0.8740000128746033},{"id":"https://openalex.org/keywords/il12a","display_name":"IL12A","score":0.8040000200271606},{"id":"https://openalex.org/keywords/il12b","display_name":"IL12B","score":1.0},{"id":"https://openalex.org/keywords/il23a","display_name":"IL23A","score":0.9900000095367432},{"id":"https://openalex.org/keywords/gene-expression","display_name":"gene expression","score":0.7929999828338623},{"id":"https://openalex.org/keywords/pasi","display_name":"PASI","score":0.9319999814033508},{"id":"https://openalex.org/keywords/dermatology-life-quality-index","display_name":"Dermatology Life Quality Index","score":0.824999988079071},{"id":"https://openalex.org/keywords/body-surface-area","display_name":"body surface area","score":0.9279999732971191},{"id":"https://openalex.org/keywords/treatment-efficacy","display_name":"treatment efficacy","score":0.7990000247955322},{"id":"https://openalex.org/keywords/biological-therapy","display_name":"biologic therapy","score":0.6769999861717224}],"concepts":[{"id":"https://openalex.org/C2778975655","wikidata":"https://www.wikidata.org/wiki/Q420305","display_name":"Ustekinumab","level":4,"score":0.863491952419281},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8324939012527466},{"id":"https://openalex.org/C2777011040","wikidata":"https://www.wikidata.org/wiki/Q390643","display_name":"Psoriasis Area and Severity Index","level":3,"score":0.8244225978851318},{"id":"https://openalex.org/C2780564577","wikidata":"https://www.wikidata.org/wiki/Q179945","display_name":"Psoriasis","level":2,"score":0.804288387298584},{"id":"https://openalex.org/C2776173921","wikidata":"https://www.wikidata.org/wiki/Q25326609","display_name":"Dermatology Life Quality Index","level":3,"score":0.6816446185112},{"id":"https://openalex.org/C2777501473","wikidata":"https://www.wikidata.org/wiki/Q1796666","display_name":"Body surface area","level":2,"score":0.6113912463188171},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5515846014022827},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.5025293827056885},{"id":"https://openalex.org/C102652120","wikidata":"https://www.wikidata.org/wiki/Q2419430","display_name":"Therapeutic effect","level":2,"score":0.4814543128013611},{"id":"https://openalex.org/C156730664","wikidata":"https://www.wikidata.org/wiki/Q23308590","display_name":"Interleukin 23","level":4,"score":0.4311107397079468},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.38015204668045044},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.30731090903282166},{"id":"https://openalex.org/C47348012","wikidata":"https://www.wikidata.org/wiki/Q99486570","display_name":"Interleukin 17","level":3,"score":0.14666110277175903},{"id":"https://openalex.org/C2780132546","wikidata":"https://www.wikidata.org/wiki/Q348260","display_name":"Adalimumab","level":3,"score":0.07382047176361084},{"id":"https://openalex.org/C2776914184","wikidata":"https://www.wikidata.org/wiki/Q101991","display_name":"Inflammation","level":2,"score":0.06669259071350098}],"mesh":[{"descriptor_ui":"D000069549","descriptor_name":"Ustekinumab","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000069549","descriptor_name":"Ustekinumab","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003879","descriptor_name":"Dermatologic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D003879","descriptor_name":"Dermatologic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005786","descriptor_name":"Gene Expression Regulation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011565","descriptor_name":"Psoriasis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D011565","descriptor_name":"Psoriasis","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D011788","descriptor_name":"Quality of Life","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012720","descriptor_name":"Severity of Illness Index","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018450","descriptor_name":"Disease Progression","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D053760","descriptor_name":"Interleukin-23 Subunit p19","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D053762","descriptor_name":"Interleukin-12 Subunit p40","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D053765","descriptor_name":"Interleukin-12 Subunit p35","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1111/dth.12843","doi":"https://doi.org/10.1111/dth.12843","is_oa":false,"landing_page_url":"https://doi.org/10.1111/dth.12843","pdf_url":null,"source":{"id":"https://openalex.org/S67424211","display_name":"Dermatologic Therapy","issn_l":"1396-0296","issn":["1396-0296","1529-8019"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-1","norway-1","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Dermatologic Therapy","raw_type":"journal-article"},{"id":"pmid:30693647","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/30693647","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Dermatologic therapy","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9940000176429749}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":8,"referenced_works":["https://openalex.org/W1488772574","https://openalex.org/W2177763304","https://openalex.org/W2306259769","https://openalex.org/W2563853364","https://openalex.org/W2781534809","https://openalex.org/W2781997888","https://openalex.org/W2791429177","https://openalex.org/W4390717688"],"related_works":["https://openalex.org/W3009418095","https://openalex.org/W3000351712","https://openalex.org/W2013143792","https://openalex.org/W2096714100","https://openalex.org/W2168714720","https://openalex.org/W2964337215","https://openalex.org/W4407660893","https://openalex.org/W2265435010","https://openalex.org/W2144737869","https://openalex.org/W2932510340"],"abstract_inverted_index":{"The":[0,15,77,110,163,208],"molecular":[1,84,178],"mechanism":[2],"of":[3,9,17,25,39,59,66,96,122,143,159,183,205,210,231],"ustekinumab":[4,97,184],"action":[5],"involves":[6],"an":[7,57],"interruption":[8],"signaling":[10],"pathways":[11],"activated":[12],"by":[13,33],"IL-12/23.":[14],"aim":[16],"this":[18],"paper":[19],"was":[20,169],"to":[21,227],"evaluate":[22,228],"the":[23,26,37,62,94,136,150,157,160,166,174,181,195,203,222,229],"efficacy":[24,182],"anti-IL12/23":[27],"therapy":[28,98,161,185],"in":[29,36,61,186,202],"seven":[30],"psoriatic":[31],"patients":[32,187],"assessing":[34],"changes":[35,60,201],"values":[38,121,142],"psoriasis":[40,189],"area":[41,53],"and":[42,56,83,105,177,200,234],"severity":[43],"index":[44,49],"(PASI),":[45],"dermatology":[46],"life":[47],"quality":[48],"(DLQI),":[50],"body":[51],"surface":[52],"(BSA)":[54],"indexes,":[55,146,199],"analysis":[58,179,209],"mRNA":[63],"expression":[64,204,214],"profile":[65],"genes":[67,168],"IL12A,":[68,87,211],"IL12B,":[69,88,212],"IL23A":[70,213],"during":[71,117],"three":[72],"40-week":[73],"long":[74],"observation":[75],"periods.":[76],"clinical":[78,176],"(PASI,":[79],"DLQI,":[80],"BSA":[81,131,145],"indexes)":[82],"(RTqPCR":[85],"for":[86,120,221],"IL23A)":[89],"analyses":[90],"were":[91,114],"performed":[92],"on":[93],"day":[95],"initiation,":[99],"4":[100],"weeks":[101,108],"post":[102],"first":[103],"administration,":[104],"every":[106],"12":[107],"thereafter.":[109],"statistically":[111],"significant":[112],"differences":[113],"observed":[115,140],"only":[116],"Stage":[118],"I":[119],"PASI":[123],"(p":[124,128,132],"=":[125,129,133],"0.0134),":[126],"DLQI":[127,198],"0.01299),":[130],"0.0355).":[134],"During":[135],"subsequent":[137],"stages,":[138],"we":[139],"lower":[141],"PASI,":[144,196],"which":[147],"suggests":[148,180],"that":[149],"lesions":[151],"are":[152],"less":[153],"intensified":[154],"than":[155],"at":[156],"moment":[158],"commencing.":[162],"relationship":[164],"between":[165],"selected":[167,206],"observed:":[170],"IL23A>IL12A>IL12B.":[171],"In":[172],"conclusion,":[173],"aforementioned":[175],"with":[188,194],"vulgaris":[190],"can":[191],"be":[192],"analyzed":[193],"BSA,":[197],"genes.":[207],"may":[215],"serve":[216],"as":[217],"a":[218],"valuable":[219],"supplementation":[220],"therapeutic":[223],"methods":[224],"currently":[225],"used":[226],"degree":[230],"disease":[232],"progression":[233],"treatment":[235],"efficacy.":[236]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2024,"cited_by_count":2},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":3}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2019-02-21T00:00:00"}